Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists

This invention relates to compounds which are generally IP receptor antagonists and which are represented by Formula I: ##STR1##

wherein G¹ is selected from the group consisting of a, b¹ and b², ##STR2##

and A and G² are as defined in the specification; or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and methods of preparation thereof.